FDA — authorised 19 November 1946
- Marketing authorisation holder: EDISON THERAPS LLC
- Status: approved
🇺🇸 Methergine in United States
FDA authorised Methergine on 19 November 1946
Marketing authorisations
FDA — authorised 19 November 1946
- Application: NDA006035
- Marketing authorisation holder: EDISON THERAPS LLC
- Local brand name: METHERGINE
- Indication: TABLET — ORAL
- Status: approved
Methergine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Methergine approved in United States?
Yes. FDA authorised it on 19 November 1946; FDA authorised it on 19 November 1946.
Who is the marketing authorisation holder for Methergine in United States?
EDISON THERAPS LLC holds the US marketing authorisation.